QIAGEN N.V.

(QGEN)
  Report
Delayed Nyse  -  05/20 04:00:02 pm EDT
45.27 USD   +1.84%
05/19QIAGEN's Eco-Friendlier Products Earn Prestigious ACT Label
BU
05/16QIAGEN NV : Berenberg keeps its Buy rating
MD
05/16QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-Dx Rise and Enhanced Panels
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
All news about QIAGEN N.V.
05/19QIAGEN's Eco-Friendlier Products Earn Prestigious ACT Label
BU
05/16QIAGEN NV : Berenberg keeps its Buy rating
MD
05/16QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-D..
BU
05/16QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-D..
CI
05/11SECTOR UPDATE : Health Care Stocks Edging Lower Ahead of Wednesday Close
MT
05/11SECTOR UPDATE : Health Care Stocks Still Hanging on for Small Advance
MT
05/11Qiagen to Acquire 96% Stake In BLIRT for Undisclosed Sum
MT
05/11QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A.
BU
05/11QIAGEN Proposes Expansion of Supervisory Board
BU
05/11Qiagen N.V. agreed to acquire 96.3% stake in BLIRT S.A. from N50 Cyprus Limited, Marian..
CI
05/10TRANSCRIPT : QIAGEN N.V. Presents at Bank of America 2022 Healthcare Conference, May-10-20..
CI
05/05QIAGEN Adds HSV1/2 Herpes Assay With CE-IVD Certification for Use on NeuMoDx Integrated..
BU
04/29QIAGEN N.V. : Release of a capital market information
EQ
04/29QIAGEN NV : Buy rating from JP Morgan
MD
04/28TRANSCRIPT : Qiagen N.V., Q1 2022 Earnings Call, Apr 28, 2022
CI
04/28Qiagen N.V. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/28Qiagen sees no immediate impact from global supply bottlenecks
RE
04/27QIAGEN NV : UBS gives a Neutral rating
MD
04/27QIAGEN NV : Gets a Buy rating from Deutsche Bank
MD
04/26Diagnostics Group Qiagen Raises FY22 Guidance After Exceeding Sales Expectations in Q1
MT
04/26Qiagen Reports Higher Q1 Results, Raises 2022 Outlook
MT
04/26QIAGEN : Q1 Earnings Snapshot
AQ
04/26QIAGEN exceeds outlook for Q1 2022, delivers strong 14% CER sales growth from non-COVID..
BU
04/26Qiagen Trading Halted Pending News Release; Shares Down 2.2% at Last Look
MT
04/26Qiagen N.V. Revises Net Sales Guidance for the Full Year 2022
CI
04/26QIAGEN N.V. : QIAGEN increases full-year 2022 outlook
EQ
04/25QIAGEN N : gives drug research direct access to world-leading data with launch of Biomedic..
PU
04/21QIAGEN N : Certificate Product Life Cycle Assessment
PU
04/20QIAGEN N.V. to release results for Q1 2022 and hold Webcast
BU
04/20QIAGEN NV : DZ Bank maintains a Buy rating
MD
04/14QIAGEN NV : Deutsche Bank reaffirms its Buy rating
MD
04/07QIAGEN N : EZ2 Connect wins prestigious Red Dot design award
PU
04/05QIAGEN N.V. : Notification and public disclosure of transactions by persons
EQ
04/05QIAGEN NV : DZ Bank reiterates its Buy rating
MD
03/31QIAGEN N : Global Environmental Health Safety Policy
PU
03/25QIAGEN N.V. : Notification and public disclosure of transactions by persons
EQ
03/24Qiagen Reaches Milestone With 100 Million Blood Tests Used to Detect Tuberculosis
MT
03/24QIAGEN Reaches Milestone With 100 Million QuantiFERON Tests Used to Detect TB
BU
03/18QIAGEN N.V. : Notification and public disclosure of transactions by persons
EQ
03/15TRANSCRIPT : QIAGEN N.V. Presents at Barclays Global Healthcare Conference 2022, Mar-15-20..
CI
03/14QIAGEN Announces 20-F Annual Report Filing for 2021 Results
BU
03/14QIAGEN N : Annual Report by Foreign Issuer (Form 20-F)
PU
03/14Tranche Update on QIAGEN N.V.'s Equity Buyback Plan announced on July 20, 2021.
CI
03/08TRANSCRIPT : QIAGEN N.V. Presents at 42nd Annual Cowen Health Care Conference, Mar-08-2022..
CI
03/03QIAGEN N.V. : Notification and public disclosure of transactions by persons
EQ
03/02QIAGEN N : and NHS England deepen bioinformatics relationship with agreement for HGMD Prof..
PU
02/28Singular Genomics Partners with Qiagen to Enable QIAseq Kits for the G4 Sequencing Plat..
CI
02/23QIAGEN N.V. : Notification and public disclosure of transactions by persons
EQ
02/23TRANSCRIPT : QIAGEN N.V. Presents at Citi’s 2022 Virtual Healthcare Conference, Feb-2..
CI
02/22Element Biosciences Partners with Qiagen to Validate a Selection of Qiaseq Targeted Lib..
CI
02/17QIAGEN NV : Receives a Buy rating from DZ Bank
MD
02/10UBS Adjusts Qiagen N.V Price Target to $55 From $57, Maintains Neutral Rating
MT
02/09QIAGEN NV : Goldman Sachs reiterates its Neutral rating
MD
02/09TRANSCRIPT : QIAGEN N.V., Q4 2021 Earnings Call, Feb 09, 2022
CI
02/09QIAGEN : Q4 Earnings Snapshot
AQ
02/09QIAGEN NV : Deutsche Bank reiterates its Buy rating
MD
02/09QIAGEN NV : Jefferies sticks Neutral
MD
02/08Qiagen forecasts profit above estimates as non-COVID businesses rebound
RE
02/08Qiagen N.V Q4 Results Top Street Expectations, Sets Upbeat EPS Guidance
MT
02/08QIAGEN beats outlook for fourth quarter and full-year 2021, delivers 22% CER full-year ..
BU
02/08QIAGEN N.V. Provides Sales Guidance for the First Quarter and Full Year of 2022
CI
02/08EARNINGS REACTION HISTORY : Qiagen N V, 50.0% Follow-Through Indicator, 2.0% Sensitive
MT
02/08QIAGEN N.V. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
02/08QIAGEN N.V. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021
CI
02/07Qiagen Gets Chinese Regulatory Approval for Tuberculosis Test
MT
02/07QIAGEN's New Generation of QuantiFERON TB Test Gains Chinese Approval and Renewed WHO R..
BU
02/07Qiagen N.V. Announces New Generation of Quantiferon TB Test Gains Chinese Approval and ..
CI
01/27QIAGEN's Commitment to LGBTQ+ and Gender Equality Recognized by Human Rights Campaign a..
BU
01/25QIAGEN Completes U.S. Federal Contract to Equip Local Public Health Authorities with QI..
BU
01/25QIAGEN Completes U.S. Federal Contract to Equip Local Public Health Authorities with QI..
CI
01/21QIAGEN N : Earnings Document
PU
01/19Qiagen N.V Launched Higher on M&A Chatter
MT
01/19QIAGEN N : supports young biotechnology and pharma companies by announcing winners of firs..
PU
01/19QIAGEN N.V. to release results for Q4 2021 and Full-Year of 2021
BU
01/18QIAGEN Launches QIAwave Portfolio of Environmentally Friendly Products
BU
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on QIAGEN N.V.